Published in Mol Biol on May 01, 2006
Bright monomeric near-infrared fluorescent proteins as tags and biosensors for multiscale imaging. Nat Commun (2016) 0.80
The Role of Dihydroorotate Dehydrogenase in Apoptosis Induction in Response to Inhibition of the Mitochondrial Respiratory Chain Complex III. Acta Naturae (2014) 0.79
[A lentivirus vector based assay system for quantitative detection of intracellular translocations of recombinant proteins]. Mol Biol (Mosk) (2009) 0.76
Image-predicated sorting of adherent cells using photopatterned hydrogels. Adv Healthc Mater (2012) 0.75
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Identification of novel genes coding for small expressed RNAs. Science (2001) 44.44
Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature (2001) 38.75
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (2001) 31.33
An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature (2000) 23.17
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev (2002) 10.71
Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell (2002) 10.30
A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 8.67
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A (2002) 8.57
Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet (2005) 8.23
Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science (2004) 7.75
The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev (2002) 7.61
Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol (2003) 7.38
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A (2001) 7.12
A genetic screen for candidate tumor suppressors identifies REST. Cell (2005) 5.61
Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci U S A (1998) 5.28
Microarrays of cells expressing defined cDNAs. Nature (2001) 5.05
Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett (2005) 4.63
Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A (2002) 3.53
A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell (2005) 3.35
Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol (2001) 2.40
Cell microarrays and RNA interference chip away at gene function. Nat Genet (2005) 1.56
Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther (2002) 1.46
RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age. Oncogene (2004) 1.40
RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. Proc Natl Acad Sci U S A (2004) 1.29
MicroRNAs: hidden in the genome. Curr Biol (2002) 1.26
Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc Natl Acad Sci U S A (1996) 1.21
A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J Virol (1996) 1.20
RNA interference in biology and disease. Blood (2005) 1.18
RNAi the natural way. Nat Genet (2005) 1.15
Induction of stable RNA interference in mammalian cells. Gene Ther (2006) 1.15
[Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors]. Mol Biol (Mosk) (2005) 0.90
Silencing of Bruton's tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA). FEBS Lett (2002) 0.89
Discovery and properties of GFP-like proteins from nonbioluminescent anthozoa. Methods Biochem Anal (2006) 0.82
Biology calls the targets: combining RNAi and disease biology. Drug Discov Today (2005) 0.79
Expression of the H-2 antigenic complex on murine haematopoietic stem cells. Scand J Immunol (1982) 0.78
A variation in the structure of the protein-coding region of the human p53 gene. Gene (1988) 3.03
The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36
Chromosome changes caused by alterations of p53 expression. Mutat Res (1996) 1.22
Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene (2005) 1.07
Escherichia coli and Pseudomonas putida RNA polymerases display identical contacts with promoters. Mol Gen Genet (1984) 1.05
Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett (1998) 1.00
P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene (1999) 0.94
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J Cell Sci (1998) 0.94
The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts. Gene (1998) 0.94
p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system. Cell Biol Int (1999) 0.93
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene (2001) 0.93
Studies of the transcription of viral genome in adenovirus 5 transformed cells. Nucleic Acids Res (1978) 0.90
[Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors]. Mol Biol (Mosk) (2005) 0.90
Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice. Immunol Lett (1988) 0.89
[Reaction of pyrophosphorolysis catalyzed by Escherichia coli RNA polymerase]. Mol Biol (Mosk) (1981) 0.89
Transcription of viral sequences in cells transformed by adenovirus Type 5. Virology (1978) 0.88
Processive pyrophosphorolysis of RNA by Escherichia coli RNA polymerase. FEBS Lett (1982) 0.87
[Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53]. Mol Biol (Mosk) (2007) 0.86
Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther (2004) 0.86
[Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor]. Mol Biol (Mosk) (1995) 0.86
Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett (1995) 0.86
[A method for obtaining the normalized cDNA libraries based on the effect of suppression of polymerase chain reaction]. Bioorg Khim (1996) 0.86
Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene (1995) 0.85
[Functional heterogeneity of p53-responsive elements]. Mol Biol (Mosk) (1996) 0.85
[Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines]. Mol Biol (Mosk) (2005) 0.84
Localization of apolipoprotein E in normal and atherosclerotic human aorta. Atherosclerosis (1990) 0.84
Combining the technique of RNA fingerprinting and differential display to obtain differentially expressed mRNA. Biochem Biophys Res Commun (1996) 0.83
The existence of DNA sequences homologous to adenovirus 5 DNA in the genome of normal rat cells. Nucleic Acids Res (1979) 0.83
[The structure and specific features of the cDNA expression of the human gene MRPL37]. Bioorg Khim (2004) 0.83
[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference]. Mol Biol (Mosk) (2010) 0.83
[Structural organization of the human p53 gene. I. Molecular cloning of the human p53 gene]. Genetika (1987) 0.82
[Isolation of a plasmid clone containing the mRNA sequence for mouse nonviral T-antigen]. Dokl Akad Nauk SSSR (1982) 0.81
[Alternative transcripts from POLRMT responsible for synthesis of nuclear RNA polymerase IV]. Mol Biol (Mosk) (2005) 0.81
Transcription of the viral genome in cell lines transformed by simian virus 40. I. Mapping of virus-specific nuclear RNAs. Nucleic Acids Res (1980) 0.81
Hydroxyl radical generation and DNA strand scission mediated by natural anticancer and synthetic quinones. FEBS Lett (1989) 0.81
[Pyrophosphate analogs in the pyrophosphorolysis reaction catalyzed by Escherichia coli RNA polymerase]. Mol Biol (Mosk) (1982) 0.80
[Construction of a reporter system for fine quantitative assessment of activity of p53 protein in cultured cells]. Mol Biol (Mosk) (2004) 0.80
Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts. Oncol Res (1995) 0.79
[The protective role of p53 in Ras-induced transformation of REF52 cells]. Mol Biol (Mosk) (2003) 0.79
Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells. Oncol Res (1997) 0.79
[Genome-wide lentivector-based pooled shRNA library optimization]. Mol Biol (Mosk) (2006) 0.79
[Apoptin enhances the oncolytic activity of vaccinia virus]. Mol Biol (Mosk) (2014) 0.79
[Oncolytic poxviruses]. Mol Gen Mikrobiol Virusol (2012) 0.78
Constitutive and induced functions of the p53 gene. Biochemistry (Mosc) (2010) 0.78
[P66shc action on resistance of colon carcinoma RKO cells to oxidative stress]. Mol Biol (Mosk) (2012) 0.78
[Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability]. Genetika (2000) 0.78
[Oncolytic enteroviruses]. Mol Biol (Mosk) (2012) 0.78
[Topography of the interaction of bacterial RNA polymerase subunits with lac UV5 promotor]. Dokl Akad Nauk SSSR (1981) 0.78
[Antisense RNA p53 inhibits proliferation of normal and transformed cells]. Mol Biol (Mosk) (1989) 0.78
The use of syngeneic cells producing human somatotropic hormone (hSTH) for immunization of mice and development of hybridomas. Hybridoma (1990) 0.77
[The human adenosine deaminase gene contains a p53-responsive element]. Dokl Akad Nauk (1996) 0.77
A study of viral genomes in cells transformed by the nononcogenic human adenovirus type 5 and highly oncogenic bovine adenovirus type 3. Curr Top Microbiol Immunol (1984) 0.77
[Two allelic genes of human p53 code for proteins differing with respect to amino acid sequence]. Genetika (1988) 0.77
[Protein complementation as tool for studying protein-protein interactions in living cells]. Mol Biol (Mosk) (2012) 0.77
[Oncotoxic proteins in cancer therapy: mechanisms of action]. Mol Biol (Mosk) (2015) 0.76
[Enhanced control of proliferation in telomerized cells]. Ontogenez (2007) 0.76
[Mutation of p53 is necessary for stable transformation of REF52 cells by myc+ras oncogenes]. Mol Biol (Mosk) (2000) 0.76
[Oncolytic parvoviruses. A new approaches for cancer therapy]. Vestn Ross Akad Med Nauk (2012) 0.76
[Construction of chimeric tumor suppressor p53 resistant to the dominant-negative interaction with p53 mutants]. Mol Biol (Mosk) (2002) 0.76
[Contacts of Escherichia coli RNA polymerase subunits with nucleotides of lacUV5 promoter]. Mol Biol (Mosk) (1982) 0.76
[Functional studying of promoter region of the human mrpl37 gene]. Mol Biol (Mosk) (2005) 0.76
[A lentivirus vector based assay system for quantitative detection of intracellular translocations of recombinant proteins]. Mol Biol (Mosk) (2009) 0.76
[Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives]. Mol Biol (Mosk) (2012) 0.76
[Prokaryotic and eukaryotic DNA-polymerase. I. The role of internucleotide phosphate groups in the binding of a primer with the enzyme]. Bioorg Khim (1987) 0.76
[Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells]. Vestn Ross Akad Med Nauk (2013) 0.75
[The use of p53 as a tool for human cancer therapy]. Mol Biol (Mosk) (2008) 0.75
[Induction of hyperdiploidy and chromosome breaks in LIM1215 cells expressing the exogenous mutant p53]. Genetika (1996) 0.75
A chemical method to enrich RNA by molecules having 5'-terminal triphosphate groups. Nucleic Acids Res (1981) 0.75
[Electron microscopic study of the minichromosomes in murine fibroblast cells fixed in situ]. Tsitologiia (1988) 0.75
[Oncolytic viruses in the therapy of gliomas]. Mol Biol (Mosk) (2013) 0.75
[Complementary-addressed modification of a single-stranded DNA fragment with an iron-porphyrin oligonucleotide derivative]. Bioorg Khim (1988) 0.75
[Effect of inactivating various components of the signal pathways of the tumor suppressor p53 on genomic stability]. Genetika (1999) 0.75
[Methylation of E. coli RNA polymerase with dimethylsulfate]. Mol Biol (Mosk) (1979) 0.75
[Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Genetika (1998) 0.75
[Distribution and excretion of iodamide-380 determined by roentgen fluorescence analysis]. Radiol Diagn (Berl) (1983) 0.75
[Simple sequences of the rat genome detected by hybridization with adenovirus DNA]. Dokl Akad Nauk SSSR (1984) 0.75
[New hot start technology in the polymerase chain reaction]. Biull Eksp Biol Med (1996) 0.75
[Dominant-negative inactivation of p53: the effect of the proportion between trans-dominant inhibitor and its target]. Mol Biol (Mosk) (2003) 0.75
[Calcium alginate as a protective agent in chronic dietary intake of strontium radioisotopes]. Radiobiologiia (1971) 0.75
[Structural rearrangement of the c-fos proto-oncogene locus in human melanoma M-1 cells]. Dokl Akad Nauk SSSR (1987) 0.75
[Close location of genes of interleukin 3 and granulocyte-macrophage colony-stimulating factor in the human genome]. Dokl Akad Nauk SSSR (1988) 0.75
[Effect of bases noncomplementary to the template on the effectiveness of primer interaction with DNA-polymerase alpha from the human placenta]. Mol Biol (Mosk) (1988) 0.75
Hydroxyl radical generation by oligonucleotide derivatives of anthracycline antibiotic and synthetic quinone. Chem Biol Interact (1991) 0.75
[Effects of various mutant p53 on the sensitivity of cells to cytostatics]. Biull Eksp Biol Med (1999) 0.75
Structure and function of the alpha-subunit of the GTP-binding protein Go from bovine cerebellum. J Protein Chem (1989) 0.75
[The physico-chemical state of Sr90 in the contents of the gastrointestinal tract]. Biull Eksp Biol Med (1968) 0.75
[Identification of genes activated by mutant forms of p53]. Mol Biol (Mosk) (2000) 0.75
[The suppression of the tumorigenicity of the FC3H 3V7 mouse fibroblast line by transformation with a retroviral vector coding the antisense RNA to the c-fos gene]. Dokl Akad Nauk SSSR (1990) 0.75
[Features of structural organization of mouse centrometric heterochromatin, detected during differential decondensation of chromosomes]. Tsitologiia (1989) 0.75